Biological replacement heart valves: Identification and evaluation

Cardiovascular Pathology

Volumn 12, Issue 3, 2003, Pages 119-139

  Butany, Jagdish ^a,b   Fayet, Cristina ^a   Ahluwalia, Manmeet S ^a   Blit, Patrick ^a   Ahn, Christina ^a   Munroe, Craig ^a   Israel, Noobar ^a   Cusimano, Roberto J ^a,b   Leask, Richard L ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bioprosthesis; Bioprosthetic heart valves; Heart valves

Indexed keywords

ALLOGRAFT; AORTA VALVE PROSTHESIS; BIOPROSTHESIS; CATTLE; CORONARY STENT; EVALUATION; FOOD AND DRUG ADMINISTRATION; GRAFT FAILURE; HEART VALVE REPLACEMENT; HUMAN; IMAGE QUALITY; MITRAL VALVE PROSTHESIS; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VALVE; RADIOGRAPHY; REVIEW; SWINE; THROMBOEMBOLISM; TISSUE ENGINEERING; XENOGRAFT;

EID: 0037717181     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(03)00002-4     Document Type: Review

References (107)

1. Harken D.F., Taylor W.J., LaFemme LEet al. Aortic valve replacement with a cage ball valve. Am J Cardiol. 9:1962;292.
2. David T.E., Ropchan G.C., Butany J.W. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg. 3(4):1988;501-505.
3. Walther T., Falk V., Weigl Cet al. Left ventricular remodelling after stentlessaortic valve replacement. Huysmans H., David T., Westaby S. Stentless bioprosthesis. 1999;161-165 Isis Medical Medica, Oxford, UK.
4. Lefrak E.A., Starr A. Porcine aortic valve xenograft. Cardiac valve prostheses. 1979;308-310 Appleton-Centruy-Crofts, New York.
5. Morse D., Steiner R.M., Fernandez J. Cardiac valve identification atlas and guide. Morse D. Guide to prosthetic cardiac valves. 1985;257-346 Springer-Verlag, New York.
6. Delcan J.L., Chaitman B.R., Lopez-Bescos L., Bonan R., Garcia-Dorado D., Rivera R. Hemodynamic evaluation of the Angell-Shiley porcine xenograft. J Thorac Cardiovasc Surg. 84(2):1982;297-305.
7. Angell W.W., Angell J.D., Sywak A. The Angell-Shiley porcine xenograft. Ann Thorac Surg. 28(6):1979;537-553.
8. Kagawa Y., Tabayashi K., Suzuki Y., Ito T., Sato N., Horiuchi T. Intermediate term results of isolated mitral valve replacement with glutaraldehyde-preserved porcine xenograft valve: clinical and hemodynamic comparison between Hancock valve and Angell-Shiley valve. Tohoku J Exp Med. 150(1):1986;37-50.
9. Cunanan C.M., Cabiling C.M., Dinh T.T., Shen S.H., Tran-Hata P., Rutledge J.H., Fishbein M.C. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg. 71(5 Suppl):2001;S417-S421.
10. Morse D., Steiner R.M., Fernandez J. Cardiac valve identification atlas and guide. Morse D. Guide to prosthetic cardiac valves. 1985;257-346 Springer-Verlag, New York.
11. Jamieson W.R., Rosado L.J., Munro A.I., Gerein A.N., Burr L.H., Miyagishima R.T., Janusz M.T., Tyers G.F. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg. 46(2):1988;155-162.
12. Curcio C.A., Commerford P.J., Rose A.G., Stevens J.E., Barnard M.S. Calcification of glutaraldehyde-preserved porcine xenografts in young patients. J Thorac Cardiovasc Surg. 81(4):1981;621-625.
13. Fann J.I., Miller D.C., Moore K.A., Mitchell R.S., Oyer P.E., Stinson E.B., Robbins R.C., Reitz B.A., Shumway N.E. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg. 62(5):1996;1301-1311.
14. Jamieson WR, Munro AI, Miyagishima RT, Allen P, Janusz MT, Gerein AN, Burr LH, Ling H, Hayden RI, Tutassura H, Macnab J, Chan F, Tyers GF. Carpentier-Edwards S.A.V. bioprosthesis: clinical report. USA: Baxter Healthcare, 1990.
15. Carpentier-Edwards S.A.V. bioprosthesis. 826-CV. USA: Baxter Healthcare, 1990.
16. Carpentier-Edwards S.A.V. bioprosthesis. Specially modified stent: an important development in low pressure bioprosthesis durability. 536-6/88-CV. USA: Baxter Healthcare, 1988.
17. Hartz R.S., Fisher E.B., Finkelmeier B., DeBoer A., Sanders J.H., Moran J.M., Michaelis L.L. An eight-year experience with porcine bioprosthetic cardiac valves. J Thorac Cardiovasc Surg. 91(6):1986;910-917.
18. Milano A., Bortolotti U., Talenti E., Valfre C., Arbustini E., Valente M., Mazzucco A., Gallucci V., Thiene G. Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol. 53(8):1984;1066-1070.
19. Milano A.D., Bortolotti U., Mazzucco A., Guerra F., Stellin G., Talenti E., Thiene G., Gallucci V. Performance of the Hancock porcine bioprosthesis following aortic valve replacement: considerations based on a 15-year experience. Ann Thorac Surg. 46(2):1988;216-222.
20. Santini F., Luciani G.B., Restivo S., Casali G., Pessotto R., Bertolini P., Rossi A., Mazzucco A. Over twenty-year follow-up of the standard Hancock porcine bioprosthesis implanted in the mitral position. Ann Thorac Surg. 71(5 Suppl):2001;S232-S235.
21. Cohn L.H., Sanders J.H., Collins J.J. Aortic valve replacement with the Hancock porcine xenograft. Ann Thorac Surg. 22(3):1976;221-227.
22. Cohn L.H., Collins J.J., Rizzo R.J., Adams D.H., Couper G.S., Aranki S.F. Twenty-year follow-up of the Hancock Modified Orifice porcine aortic valve. Ann Thorac Surg. 66(6 Suppl):1998;S30-S34.
23. Khan S.S., Mitchell R.S., Derby G.C., Oyer P.E., Miller D.C. Differences in Hancock and Carpentier-Edwards porcine xenograft aortic valve hemodynamics. Effect of valve size. Circulation. 82(5 Suppl):1990;IV117-IV124.
24. Hancock Modified Orifice bioprosthesis performance update: seventeen years experience. Medtronic, 1995.
25. Arbustini E., Jones M., Moses R.D., Eidbo E.E., Carroll R.J., Ferrans V.J. Modification by the Hancock T6 process of calcification of bioprosthetic cardiac valves implanted in sheep. Am J Cardiol. 53(9):1984;1388-1396.
26. Eichinger W., Gunzinger R., Botzenhardt F., Simmerl D., Gansera B., Kemkes B.M. Mosaic bioprosthesis after 5 years. Herz. 25(7):2000;659-666.
27. Butany J., Yu W., Silver M.D., David T.E. Morphologic findings in explanted Hancock II porcine bioprostheses. J Heart Valve Dis. 8(1):1999;4-15.
28. David T.E., Ivanov J., Armstrong S., Feindel C.M., Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 121(2):2001;268-277.
29. Butterfield M., Fisher J., Kearney J.N., Davies G.A. Hydrodynamic function of second generation porcine bioprosthetic heart valves. J Card Surg. 6(4):1991;490-498.
30. Barratt-Boyes B.G., Jaffe W.M., Whitlock R.M. The Medtronic Intact porcine valve: ten-year clinical review. J Thorac Cardiovasc Surg. 116(6):1998;1005-1014.
31. Duarte I.G., MacDonald M.J., Cooper W.A., Schmarkey S.L., Gott J.P., Brown W.M., Vinten-Johansen J., Guyton R.A. In vivo hemodynamic, histologic, and antimineralization characteristics of the Mosaic bioprosthesis. Ann Thorac Surg. 71(1):2001;92-99.
32. Medtronic. Physiologic fixation: advancing porcine valve fixation technology. USA: Medtronic, 2000.
33. Caimmi P.P., Di Summa M., Galloni M., Gastaldi L., Papillo B., Actis Dato G.M., Agaccio G., Donegani E., Poletti G., Morea M. Twelve-year follow up with the Sorin Pericarbon bioprosthesis in the mitral position. J Heart Valve Dis. 7(4):1998;400-406.
34. Fradet G.J., Bleese N., Burgess J., Cartier P.C. Mosaic valve international clinical trial: early performance results. Ann Thorac Surg. 71(5 Suppl):2001;S273-S277.
35. Wong S.P., Legget M.E., Greaves S.C., Barratt-Boyes B.G., Milsom F.P., Raudkivi P.J. Early experience with the mosaic bioprosthesis: a new generation porcine valve. Ann Thorac Surg. 69(6):2000;1846-1850.
36. Vrandecic M., Fantini F.A., Filho B.G., de Oliveira O.C., da Costa I.M., Vrandecic E. Retrospective clinical analysis of stented vs. stentless porcine aortic bioprostheses. Eur J Cardiothorac Surg. 18(1):2000;46-53.
37. Bottio T., Rizzoli G., Gerosa G., Thiene G., Casarotto D. Mid-term follow-up in patients with Biocor porcine bioprostheses. Cardiovasc Surg. 10(3):2002;238-244.
38. SJM Products. St. Jude Medical website ( www.sjm.com ). 2002.
39. Myken P., Bech-Hanssen O., Phipps B., Caidahl K. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis. J Heart Valve Dis. 9(3):2000;415-422.
40. Myken P.S., Caidahl K., Larsson S., Berggren H.E. 10-Year experience with the Biocor porcine bioprosthesis in the mitral position. J Heart Valve Dis. 4(1):1995;63-69.
41. Kirali K., Guler M., Tuncer A., Daglar B., Ipek G., Isik O., Yakut C. Fifteen-year clinical experience with the biocor porcine bioprostheses in the mitral position. Ann Thorac Surg. 71(3):2001;811-815.
42. Demirag M., Kirali K., Omeroglu S.N., Mansuroglu D., Akinci E., Ipek G., Berki T., Gurbuz A., Isik O., Yakut C. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves. J Heart Valve Dis. 10(1):2001;78-83.
43. Myken P.S., Caidahl K., Larsson S., Berggren H.E. 10-Year experience with the Biocor porcine bioprosthesis in the aortic position. J Heart Valve Dis. 3(6):1994;648-656.
44. Langanki D., Ogle M.F., Cameron J.D., Lirtzman R.A., Schroeder R.F., Mirsch M.W. Evaluation of a novel bioprosthetic heart valve incorporating anticalcification and antimicrobial technology in a sheep model. J Heart Valve Dis. 7(6):1998;633-638.
45. Flameng W.J., Ozaki S., Yperman J., Herijgers P., Meuris B., Van Lommel A., Verbeken E. Calcification characteristics of porcine stented valves in a juvenile sheep model. Ann Thorac Surg. 71(5 Suppl):2001;S401-S405.
46. Edwards Life Sciences website ( www.edwards.com ). 2002.
47. Khan S. Cedars-Sinai heart valve website. Cedars-Sinai Medical Center prosthetic heart valve information page. 6-18-1998.
48. Butany J., Leask R. The failure modes of biological prosthetic heart valves. J Long-Term Eff Med Implants. 11(3-4):2001;115-135.
49. Marchand M., Aupart M., Norton R., Goldsmith I.R., Pelletier C., Pellerin M., Dubiel T., Daenen W., Casselman F., Holden M., David T.E., Ryba E.A. Twelve-year experience with Carpentier-Edwards PERIMOUNT pericardial valve in the mitral position: a multicenter study. J Heart Valve Dis. 7(3):1998;292-298.
50. Frater R.W., Salomon N.W., Rainer W.G., Cosgrove D.M., Wickham E. The Carpentier-Edwards pericardial aortic valve: intermediate results. Ann Thorac Surg. 53(5):1992;764-771.
51. Masters R.G., Walley V.M., Pipe A.L., Keon W.J. Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg. 60(2 Suppl):1995;S288-S291.
52. Ott D.A., Cooley D.A., Reul G.J., Duncan J.M., Frazier O.H., Livesay J.J. Ionescu-Shiley bovine pericardial bioprostheses. Stephenson L.W. Cardiology clinics: symposium on cardiac valve surgery. 1985;343-369 Saunders, Toronto.
53. Bartek I.T., Holden M.P., Ionescu M.I. Frame-mounted tissue heart valves: technique of construction. Thorax. 29(1):1974;51-55.
54. Schoen F.J., Fernandez J., Gonzalez-Lavin L., Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation. 76(3):1987;618-627.
55. Brais M.P., Bedard J.P., Goldstein W., Koshal A., Keon W.J. Ionescu-Shiley pericardial xenografts: follow-up of up to 6 years. Ann Thorac Surg. 39(2):1985;105-111.
56. Walley V.M., Keon C.A., Khalili M., Moher D., Campagna M., Keon W.J. Ionescu-Shiley valve failure: I. Experience with 125 standard-profile explants. Ann Thorac Surg. 54(1):1992;111-116.
57. Masters R.G., Pipe A.L., Bedard J.P., Brais M.P., Goldstein W.G., Koshal A., Keon W.J. Long-term clinical results with the Ionescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg. 101(1):1991;81-89.
58. Mehlman D.J., Resnekov L. A guide to the radiographic identification of prosthetic heart valves. Circulation. 57(3):1978;613-623.
59. Mehlman D.J. A pictorial and radiographic guide for identification of prosthetic heart valve devices. Prog Cardiovasc Dis. 30(6):1988;441-464.
60. Walley V.M., Keon W.J. Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg. 93(6):1987;925-933.
61. Wheatley D.J., Crawford F.A., Kay P.H., Chandler J.G., Strong M.D., Strom J.A., Shah P.M., Keon W.J., Copeland G., Lewis S.S. A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve. Eur J Cardiothorac Surg. 8(10):1994;541-548.
62. Wheatley D.J., Crawford F.A., Kay P.H., Chandler J.G., Strong M.D., Strom J.A., Shah P.M., Keon W.J., Copeland G., Lewis S.S. A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve. Eur J Cardiothorac Surg. 8(10):1994;541-548.
63. Butany J., Vanlerberghe K., Silver M.D. Morphologic findings and causes of failure in 24 explanted Ionescu-Shiley low-profile pericardial heart valves. Hum Pathol. 23(11):1992;1224-1233.
64. Mehlman D.J. A guide to the radiographic identification of prosthetic heart valves: an addendum. Circulation. 69(1):1984;102-105.
65. Walley V.M., Bedard P., Brais M., Keon W.J. Valve failure caused by cusp tears in low-profile Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg. 93(4):1987;583-586.
66. Garcia-Bengochea J.B., Casagrande I., Gonzalez-Juanatey J.R., Puig L., Rubio J., Duran D., Sierra J. The new Labcor-Santiago pericardial bioprosthesis. J Card Surg. 6(4 Suppl):1991;613-619.
67. Gonzalez-Juanatey J.R., Garcia-Bengoechea J.B., Vega M., Rubio J., Sierra J., Duran D., Amaro A., Gil M. Echocardiographic features of the normofunctional Labcor-Santiago pericardial bioprosthesis. J Heart Valve Dis. 3(5):1994;548-555.
68. Gonzalez-Juanatey J.R., Garcia-Acuna J.M., Vega F.M., Amaro C.A., Castelo F.V., Garcia-Bengoechea J.B., Gil dlP Hemodynamics of various designs of 19 mm pericardial aortic valve bioprosthesis. Eur J Cardiothorac Surg. 10(3):1996;201-206.
69. Sulzer Mitroflow website ( www.mitroflow.com ). 6-14-2002.
70. Pomar J.L., Jamieson W.R., Pelletier L.C., Castella M., Germann E., Brownlee R.T. Mitroflow pericardial bioprosthesis experience in aortic valve replacement > or =60 years of age. Ann Thorac Surg. 66(6 Suppl):1998;S53-S56.
71. Houel R., Le Besnerais P., Soustelle C., Kirsch M., Hillion M.L., Loisance D. Lack of durability of the Mitroflow valve does not affect survival. J Heart Valve Dis. 8(4):1999;368-374.
72. Grabenwoger M., Grimm M., Leukauf C., Szeles C., Feichtinger E., Muller M.M., Moritz A., Bock P., Wolner E. Failure mode of a new pericardial valve prosthesis (Sorin Pericarbon). A morphological study. Eur J Cardiothorac Surg. 8(9):1994;470-476.
73. Seguin J.R., Grandmougin D., Folliguet T., Warembourg H., Laborde F., Chaptal P.A. Long-term results with the Sorin Pericarbon valve in the aortic position: a multicenter study. J Heart Valve Dis. 7(3):1998;278-282.
74. Hvass U., Palatianos G.M., Frassani R., Puricelli C., O'Brien M. Multicenter study of stentless valve replacement in the small aortic root. J Thorac Cardiovasc Surg. 117(2):1999;267-272.
75. Gelsomino S., Frassani R., Morocutti G., Porreca L., Tursi V., Masullo G., Lumini R., Livi U. Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis. J Heart Valve Dis. 10(5):2001;603-610.
76. Elkins R.C., Goldstein S., Hewitt C.W., Walsh S.P., Dawson P.E., Ollerenshaw J.D., Black K.S., Clarke D.R., O'Brien M.F. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg. 13(4 Suppl 1):2001;87-92.
77. Goldstein S., Clarke D.R., Walsh S.P., Black K.S., O'Brien M.F. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg. 70(6):2000;1962-1969.
78. Walsh SP, Goldstein S, Bair C, Black KS. A tissue engineered heart valve: in vitro performance of the SynerGraft Heart Valve. CryoLife, 2002.
79. Peck P. Replacement heart valves built to last, and even grow: new valves could last 25 years after transplant. WebMD Health. 8-4-2000.
80. CryoLife, tissue-engineered replacement heart valve featured at international conference. PR Newswire. 6-18-2001.
81. Cardiothoracic Surgery website ( www.ctsnet.com ). 2002.
82. Jin X.Y., Ratnatunga C., Pillai R. Performance of Edwards Prima stentless aortic valve over eight years. Semin Thorac Cardiovasc Surg. 13(4 Suppl 1):2001;163-167.
83. Bortolotti U., Scioti G., Milano A., Borzoni G., Nardi C., Tartarini G. The Edwards Prima stentless valve: hemodynamic performance at one year. Ann Thorac Surg. 68(6):1999;2147-2151.
84. Bortolotti U., Milano A., Tartarini G., Scioti G., Borzoni G., Nardi C., Puccioni E. Hemodynamic performance of the Edwards Prima stentless valve. J Heart Valve Dis. 6(2):1997;134-137.
85. FDA Medical Device Approvals website ( www.fda.gov ). 9-5-2001.
86. American Association for Thoracic Surgery. American Association for Thoracic Surgery website. 2002.
87. Medtronic website ( www.medtronic.com ). 6-12-2002.
88. Melina G., Rubens M.B., Birks E.J., Bizzarri F., Khaghani A., Yacoub M.H. A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized trial. J Heart Valve Dis. 9(1):2000;97-103.
89. Yun K.L., Sintek C.F., Fletcher A.D., Pfeffer T.A., Kochamba G.S., Hyde M.R., Torpoco J.O., Khonsari S. Aortic valve replacement with the freestyle stentless bioprosthesis: five-year experience. Circulation. 100(19 Suppl):1999;II17-II23.
90. Freestyle aortic root bioprosthesis eight-year clinical compedium. Medtronic, 2002.
91. Saint Jude Medical. St. Jude Medical website. 2002.
92. Bach D.S., Goldman B., Verrier E., Petracek M., Wood J., Goldman S., David T. Eight-year hemodynamic follow-up after aortic valve replacement with the Toronto SPV stentless aortic valve. Semin Thorac Cardiovasc Surg. 13(4 Suppl 1):2001;173-179.
93. Shargall Y., Goldman B., Christakis G., David T. Analysis of explants and causes of mortality during long-term follow-up of the Toronto stentless porcine valve. Semin Thorac Cardiovasc Surg. 13(4 Suppl 1):2001;106-112.
94. David T.E., Ivanov J., Eriksson M.J., Bos J., Feindel C.M., Rakowski H. Dilation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis. J Thorac Cardiovasc Surg. 122(5):2001;929-934.
95. Hofmann B., Cichon R., Knaut M., Kappert U., Tugtekin S.M., Aron W., Schuler S. Early experience with a quadrileaflet stentless mitral valve. Ann Thorac Surg. 71(5 Suppl):2001;S323-S326.
96. Middlemost S.J., Sussman M., Patel A., Manga P. The stentless quadrileaflet bovine pericardial mitral valve: early clinical results. J Heart Valve Dis. 8(2):1999;174-179.
97. Aybek T., Simon A., Dogan S., Greinecker G.W., Moritz A. Two years' clinical experience with a quadrileaflet stentless bioprosthesis in the mitral position. J Heart Valve Dis. 9(5):2000;667-673.
98. CryoLife, advances application of its tissue-engineered human heart valves. Canada NewsWire. 8-11-2000.
99. SynerGraft Cryovalve SG & S.G. Cryopatch. CryoLife, 2002.
100. Elkins R.C., Lane M.M., Capps S.B., McCue C., Dawson P.E. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg. 13(4 Suppl 1):2001;82-86.
101. Fischlein T., Schutz A., Haushofer M., Frey R., Uhlig A., Detter C., Reichart B. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg. 60(2 Suppl):1995;S122-S125.
102. Durbin A.D., Gotlieb A.I. Advances towards understanding heart valve response to injury. Cardiovasc Pathol. 11(2):2002;69-77.
103. Carpentier A. From valvular xenograft to valvular bioprosthesis (1965-1977). Med Instrum. 11(2):1977;98-101.
104. Grunkemeier G.L., Li H.H., Naftel D.C., Starr A., Rahimtoola S.H. Long-term performance of heart valve prostheses. Curr Probl Cardiol. 25(2):2000;73-154.
105. Rabkin E., Schoen F.J. Cardiovascular tissue engineering. Cardiovasc Pathol. 11(6):2002;305-317.
106. Fuchs J.R., Nasseri B.A., Vacanti J.P. Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg. 72(2):2001;577-591.
107. Mayer J.E., Shin'oka T., Shum-Tim D. Tissue engineering of cardiovascular structures. Curr Opin Cardiol. 12(6):1997;528-532.